|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
223,469 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,468,702 |
|
|
Indirect Value
|
$3,772,028 |
|
|
Total
Shares |
3,384,944 |
|
|
Total
Value |
$6,240,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2008-03-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
40 |
46,369 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-02-26 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,028 |
46,545 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-11-16 |
4 |
OE |
$14.28 |
$134,884 |
I/I |
9,445 |
47,417 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-03-25 |
4 |
OE |
$9.63 |
$48,125 |
I/I |
5,000 |
49,573 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-13 |
4 |
AS |
$20.04 |
$23,407 |
I/I |
(1,168) |
49,816 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-12 |
4 |
AS |
$20.01 |
$24,012 |
I/I |
(1,200) |
50,215 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-08 |
4 |
AS |
$20.09 |
$138,119 |
I/I |
(6,875) |
50,625 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-09-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
51,195 |
|
- |
|
GERN |
Geron Corporation |
Director |
|
2019-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
9,036 |
51,323 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2005-09-12 |
4 |
OE |
$6.88 |
$61,909 |
D/D |
9,005 |
51,345 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-03-22 |
4 |
OE |
$2.91 |
$488,911 |
D/D |
39,269 |
52,240 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-06 |
4 |
AS |
$20.02 |
$4,004 |
I/I |
(200) |
52,974 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-04 |
4 |
AS |
$20.08 |
$87,165 |
I/I |
(4,340) |
53,042 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-12-01 |
4 |
AS |
$20.06 |
$191,425 |
I/I |
(9,545) |
54,525 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-11-30 |
4 |
AS |
$20.08 |
$244,566 |
I/I |
(12,179) |
57,786 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2012-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,167) |
58,745 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-11-29 |
4 |
AS |
$20.13 |
$349,008 |
I/I |
(17,342) |
60,222 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2012-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
62,178 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2012-03-01 |
4 |
S |
$17.11 |
$26,332 |
D/D |
(1,539) |
62,912 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-11-24 |
4 |
AS |
$20.02 |
$16,016 |
I/I |
(800) |
63,690 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-11-21 |
4 |
AS |
$20.00 |
$6,000 |
I/I |
(300) |
63,850 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-11-20 |
4 |
AS |
$20.04 |
$115,330 |
I/I |
(5,755) |
63,910 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-09-01 |
4 |
AS |
$20.04 |
$36,112 |
I/I |
(1,802) |
65,062 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2023-07-07 |
4 |
AS |
$20.39 |
$1,019,500 |
I/I |
(50,000) |
67,805 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-11-22 |
4 |
OE |
$11.13 |
$278,125 |
I/I |
25,000 |
74,573 |
0 |
- |
|
423 Records found
|
|
Page 12 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|